ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.
Changing lives with every breath
At ResMed we believe that every breath is an opportunity to make a positive change to people’s lives. We’ve been helping to change lives since 1989 and now we’re unveiling a new brand that we believe embodies this philosophy. Have a look and see if you agree.
Our Vision and Our Mission
Our Vision is to be the global solutions leader for SDB, COPD and other major chronic diseases. Our Mission is to improve the quality of life for patients, prevent progression of chronic diseases, and reduce overall healthcare system costs.
The ResMed story
When ResMed was formed in 1989, our primary purpose was to commercialize a device for treating obstructive sleep apnea (OSA), a major subset of sleep-disordered breathing (SDB).
The executive team
ResMed’s executive team is committed to the highest standards of ethics and professional integrity, translating to great partnerships with our customers, our suppliers, and with our global ResMed team.